Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
The Journal of Rheumatology|May 17, 2011
Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritisAnne F Christensen, Hanne Lindegaard, Kim Hørslev-Petersen, et al.The Journal of Animal Ecology|January 6, 2009
Ecological networks--beyond food websThomas C Ings, José M Montoya, Jordi Bascompte, et al.Annals of the Rheumatic Diseases|May 7, 2010
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trialMerete L Hetland, Kristian Stengaard-Pedersen, Peter Junker, et al.Biological Psychiatry|October 5, 2013
A mouse model that recapitulates cardinal features of the 15q13.3 microdeletion syndrome including schizophrenia- and epilepsy-related alterationsKim Fejgin, Jacob Nielsen, Michelle R Birknow, et al.Journal of Psychiatry & Neuroscience : JPN|July 9, 2016
Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male miceMichael Didriksen, Kim Fejgin, Simon R O Nilsson, et al.Scandinavian Journal of Rheumatology|August 29, 2013
Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progressionT Ellingsen, I Hansen, J Thorsen, et al.Annals of the Rheumatic Diseases|May 11, 2013
Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trialT W Jensen, M S Hansen, K Hørslev-Petersen, et al.Blood|July 12, 2015
Disease evolution and outcomes in familial AML with germline CEBPA mutationsKiran Tawana, Jun Wang, Aline Renneville, et al.Pageof 9